Skip to main content
. 2023 Jun 3;13:9046. doi: 10.1038/s41598-023-36146-9

Figure 5.

Figure 5

Proposed role of mERα-initiated signaling after treatment with physiological and supraphysiological doses of E2. In this study, it has been shown that the sensitivity to physiological E2 treatment is reduced in both non-reproductive tissues and uterus in the absence of mERα signaling. However, with a supraphysiological E2 dose, the effect in uterus is enhanced when mERα signaling is lacking. Therefore, we suggest that mERα signaling in general enhances E2 effects within the physiological range, and that it may also partially protect the uterus from potential harm of supraphysiological levels of E2. Created with BioRender.com.